Skip to content

Free cash flow at other companies

Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
$546M
TFX
TeleflexTFX
$27.87M+676%
IAR
Integra LifeSciencesIART
-$5.05M+87.4%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$24.67M+26.5%
PDE
Pro-Dex, Inc.PDEX
$1.52M
The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO

Other financials

Income statement

See full
Revenue$8.7M-10.2%
Gross profit$5.3M-4.6%
Operating income$2.6M-18.6%
Net income$2.6M-14.4%
EPS (diluted)$0.82-10.9%

Balance sheet

See full
Cash & equivalents$87.4M+4.9%
Total debt$210.0K
Total equity$120.4M+2.8%
Total assets$124.4M+1.5%

Cash flow

See full
Operating cash flow$3.1M-30.4%
CapEx$130.0K-29.3%

Valuation

See full
Market cap$219.63M+26.4%
Enterprise value$132.44M+42.5%
P/E20.3×+6.4×
P/S5.9×+1.4×

Profitability

See full
Gross margin57.9%-0.4pp
Operating margin28.8%-3.9pp
Net margin28.9%-4.1pp
FCF margin34.7%0.0pp

Returns & leverage

See full
Return on equity9.1%-1.4pp
Debt / equity
Current ratio28.6×+6.3×

Where this comes from

Calculated from Utah Medical Products’s reported figures.

The official record: Utah Medical Products’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Utah Medical Products's free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Utah Medical Products's free cash flow?
Utah Medical Products (UTMD) reported free cash flow of $2.98M in Q1 2026.
How has Utah Medical Products's free cash flow changed year-over-year?
Utah Medical Products's free cash flow decreased by 30.4% year-over-year, from $4.28M to $2.98M.
What is the long-term trend for Utah Medical Products's free cash flow?
Over 4 years (2021 to 2025), Utah Medical Products's free cash flow has grown at a -8.7% compound annual growth rate (CAGR), from $20.65M to $14.32M.
What does free cash flow mean?
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.